FEMALE SEXUAL DYSFUNCTION
Abstract
Female sexual dysfunction affect up to 43% of women causing a "distress" or a psychological strain for the patients. A variety of chronic diseases in addition to menopause and different drugs represents the risk factors to a female sexual dysfunction. Since 2015 the FDA has approved Flibanserin for the treatment of female libido although several other drugs have been proven efficacious.
About the Authors
C. DADAK
University Clinic of obstetrics and gynecology, Vienna, Austria
Austria
University Clinic of obstetrics and gynecology Center for teaching
Austria
University Clinic of obstetrics and gynecology Center for teaching
M. BAYERLE-EDE
Medical University of Vienna, Austria
Austria
Medical University of Vienna Department of internal medicine III, Department of Endocrinology and metabolism
Austria
Medical University of Vienna Department of internal medicine III, Department of Endocrinology and metabolism
For citation:
DADAK C., BAYERLE-EDE M. FEMALE SEXUAL DYSFUNCTION. Obstetrics, Gynecology and Reproduction. 2015;9(4):86-88. (In Russ.) https://doi.org/10.17749/2070-4968.2015.9.4.086-088
Views: 232
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
